OVOSTAR UNION PUBLIC COMPANY LIMITED financials
OVOSTAR UNION PUBLIC COMPANY LIMITED
54930054O2GINV8PPT28 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Cost of sales | $76.5M | $86.6M |
| Gross profit | $62.6M | $22.8M |
| Other income | $939.0K | $547.0K |
| Administrative expenses | $3.6M | $3.8M |
| Operating profit (EBIT) | $47.0M | $7.3M |
| Finance costs | $667.0K | $555.0K |
| Profit before tax | $50.8M | $6.6M |
| Income tax expense | $5.8M | $504.0K |
| Profit for the year | $45.0M | $6.1M |
| — attributable to owners | $44.7M | $6.2M |
| — attributable to NCI | $231.0K | -$159.0K |
| Total comprehensive income | $41.2M | -$21.8M |
| Per share | ||
| Basic EPS | $7.46 | $1.04 |
| Free cash flow / share | $14.05 | $3.27 |
| Cash flow statement | ||
| Cash generated from operations | $88.3M | $19.5M |
| Net cash from operating activities | $85.7M | $19.5M |
| Net cash from investing activities | -$11.7M | -$8.7M |
| Purchase of PP&E (capex) | $1.0M | $347.0K |
| Net cash from financing activities | -$13.0M | -$1.6M |
| Dividends paid | $4.3M | $0 |
| Proceeds from borrowings | $0 | $2.5M |
| Repayments of borrowings | $8.4M | $3.7M |
| Net change in cash | $61.0M | $9.1M |
| Balance sheet | ||
| Total assets | $142.2M | $110.7M |
| Non-current assets | $37.1M | $46.6M |
| Current assets | $105.1M | $64.1M |
| Inventories | $13.6M | $12.0M |
| Trade & other receivables | $13.2M | $26.8M |
| Cash & equivalents | $72.5M | $12.2M |
| Total equity | $125.1M | $83.9M |
| — attributable to owners | $124.7M | $83.7M |
| Non-controlling interests | $443.0K | $208.0K |
| Non-current liabilities | $1.8M | $8.6M |
| Current liabilities | $15.3M | $18.2M |
| Trade & other payables | $9.7M | $12.4M |
| Deferred tax liabilities | $238.0K | $269.0K |
| Derived metrics | ||
| Free cash flow | $84.7M | $19.1M |
| Operating margin | 28.9% | 5.4% |
| Net margin | 27.7% | 4.5% |
| Return on equity | 35.9% | 7.3% |
| Cash conversion ratio | 1.91× | 3.20× |
| Capex coverage | 85.05× | 56.11× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -$2.0M | -$2.7M |
| Adjustments For Decrease Increase In Trade and Other Receivables | $15.4M | -$13.7M |
| Adjustments For Depreciation and Amortisation Expense | $3.4M | $3.8M |
| Adjustments For Finance Costs | $667.0K | $555.0K |
| Adjustments For Finance Income | $1.6M | $132.0K |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | $30.0K | $18.0K |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -$23.5M | -$26.3M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | $265.0K | $0 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$3.1M | $274.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | $235.0K | -$269.0K |
| Comprehensive Income Attributable To Owners of Parent | $41.0M | -$21.5M |
| Current Advances | $356.0K | $571.0K |
| Current Advances To Suppliers | $2.6M | $3.0M |
| Current Biological Assets | $3.2M | $10.1M |
| Current Deferred Income Including Current Contract Liabilities | $203.0K | $211.0K |
| Current Tax Assets Current | $1.0K | $1.0K |
| Current Tax Liabilities Current | $2.7M | $617.0K |
| Deferred Tax Assets | $78.0K | $185.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$709.0K | $597.0K |
| Equity and Liabilities | $142.2M | $110.7M |
| Finance Income | $1.6M | $132.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $3.1M | -$274.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | -$23.5M | -$26.3M |
| Income Taxes Paid Refund Classified As Operating Activities | $2.6M | $12.0K |
| Interest Paid Classified As Financing Activities | $667.0K | $620.0K |
| Interest Received Classified As Investing Activities | $1.6M | $0 |
| Issued Capital | $84.0K | $84.0K |
| Liabilities | $17.1M | $26.8M |
| Miscellaneous Other Operating Expense | $265.0K | $0 |
| Noncurrent Biological Assets | $9.1M | $15.0M |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | $1.5M | $1.8M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | $0 | $45.0K |
| Other Comprehensive Income | -$3.8M | -$27.9M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | $4.0K | -$110.0K |
| Other Comprehensive Income Attributable To Owners of Parent | -$3.8M | -$27.8M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -$3.8M | -$27.9M |
| Other Expense By Function | $508.0K | $186.0K |
| Proceeds From Government Grants Classified As Financing Activities | $336.0K | $164.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $127.0K | $356.0K |
| Purchase of Biological Assets | $12.4M | $8.8M |
| Reserve of Exchange Differences On Translation | -$157.5M | -$153.7M |
| Retained Earnings Excluding Profit Loss For Reporting Period | $206.4M | $200.1M |
| Retained Earnings Profit Loss For Reporting Period | $44.7M | $6.2M |
| Revenue From Contracts With Customers | $162.5M | $135.6M |
| Revenue From Government Grants | $548.0K | $406.0K |
| Share Premium | $30.9M | $30.9M |
| Weighted Average Shares | 6.0M | 6.0M |
Every line item above is a fact tagged in OVOSTAR UNION PUBLIC COMPANY LIMITED's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.